MAESTrO takes a closer look at COMPARE

Of the list of 34 medicines included in a list of new molecular entities reimbursed in 10 OECD countries but not Australia, five have been listed, eight recommended but not listed, two were considered at the March PBAC meeting, while 13 have never been submitted to the committee. …